Neon Therapeutics, Inc. (NTGN) News
Filter NTGN News Items
NTGN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest NTGN News From Around the Web
Below are the latest news stories about Neon Therapeutics Inc that investors may wish to consider to help them evaluate NTGN as an investment opportunity.
Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies – HXL, AMTD, FSB, NTGNNEW YORK, March 12, 2020 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders.. |
Lifshitz & Miller LLP Announces Investigation of Neon Therapeutics, Inc., Stein Mart, Inc., and Taubman Centers, Inc.NEW YORK, March 11, 2020 -- Neon Therapeutics, Inc. (NASDAQ:NTGN) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with. |
Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - FSB, NTGN, HXLNEW YORK, NY / ACCESSWIRE / March 9, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP ... |
MEET, AMTD, NTGN, and HXL SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of MergersWILMINGTON, Del., March 09, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: The Meet Group, Inc. (NASDAQ GS: MEET) regarding possible breaches of. |
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - HXL, NTGN, AMTDNEW YORK, NY / ACCESSWIRE / March 4, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP ... |
Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Neon Therapeutics, Central Federal Bancshares, Franklin Financial Network, and Changyou.com Limited on behalf of Stockholders and Encourages Investors to Contact the FirmNEW YORK, Jan. 24, 2020 /PRNewswire/ -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Neon Therapeutics, Inc. (NASDAQ: NTGN), Central Federal Bancshares, Inc. (Other OTC: CFDB), Franklin Financial Network, Inc…. |
Neon Therapeutics News: NTGN Stock Rockets 38% on BioNTech DealNeon Therapeutics (NTGN ) news for Thursday about a $67.00 million deal with BioNTech (BNTX) has NTGN stock soaring on Thursday. |
The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer DrugHere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 3) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Antares Pharma Inc (NASDAQ: ATRS ) Ardelyx Inc (NASDAQ: ARDX )(announced positive results for the Phase 3 study of tenapanor as monotherapy for treating hyperphosphatemia in patients with chronic kidney disease on dialysis) Audentes Therapeutics Inc (NASDAQ: BOLD )( announced a deal to be bought by ASTELLAS PHARMA/ADR (OTC: ALPMY )) Axsome Therapeutics Inc (NASDAQ: AXSM )(announced positive mid-stage readout for drug to treat narcolepsy) Cassava Sciences Inc (NASDAQ: SAVA ) Constellation Pharmaceuticals Inc (NASDAQ: CNST ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) DexCom, Inc. (NASDAQ: DXCM ) ... |
The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings EstimateHere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 21.) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Amgen, Inc. (NASDAQ: AMGN ) (raised full-year guidance following completion of Otezla purchase from Celgene) Antares Pharma Inc (NASDAQ: ATRS ) Arvinas Inc (NASDAQ: ARVN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Beigene Ltd (NASDAQ: BGNE ) BIO-TECHNE Corp (NASDAQ: TECH ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Cue Biopharma Inc (NASDAQ: CUE ) Epizyme Inc (NASDAQ: EPZM ) Kamada Ltd. (NASDAQ: KMDA ) Kodiak Sciences Inc (NASDAQ: KOD ) Molecular Templates Inc (NASDAQ: MTEM ) Recro Pharma Inc (NASDAQ: REPH ) (completed spin-off of Baudax Bio in a bid to a b... |
Neon Therapeutics (NASDAQ:NTGN) Downgraded to “Neutral” at Bank of AmericaBank of America downgraded shares of Neon Therapeutics (NASDAQ:NTGN) from a buy rating to a neutral rating in a research note released on Wednesday morning, Briefing.com Automated Import reports. Other research analysts have also recently issued reports about the company. ValuEngine upgraded Neon Therapeutics from a hold rating to a buy rating in a research […] |